Home » Authors » Anette Breindl

Articles by Anette Breindl

Surrogate Endpoints, FDA Drugs, 'Disease Mongering'

May 8, 2006

By Anette Breindl and Aaron Lorenzo

Expanding Fusion's Potential By Delivering Health Triplets

May 3, 2006

By Anette Breindl

Expanding Fusion's Potential By Delivering Health Triplets

May 3, 2006

By Anette Breindl

'Flipping' Providing New Way For Payload Delivery To Cells

April 25, 2006

By Anette Breindl

'Flipping' Providing New Way For Payload Delivery To Cells

April 25, 2006

By Anette Breindl

Parasite Infections May Provide Dual Anti-Inflammatory Defense

April 20, 2006

By Anette Breindl

Parasite Infections May Provide Dual Anti-Inflammatory Defense

April 20, 2006

By Anette Breindl

Studying Receptor Function Yielding Targets For Disease

April 19, 2006

By Anette Breindl

Viral, Host Receptor Studies Suggest Kaposi's Therapies

April 19, 2006

By Anette Breindl

Viral, Host Receptor Studies Suggest Kaposi's Therapies

April 19, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...